145 results
Page 5 of 8
6-K
EX-99.1
xhncxkgk8w87tdumvl
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
EX-99.1
oee9jejo42oc5rbjq
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am
6-K
EX-99.1
mm5jg x61vpnw3xv
13 Nov 19
Current report (foreign)
7:55am
6-K
EX-99.2
4uc2qfk 1ktmfj
13 Nov 19
Current report (foreign)
7:55am
6-K
EX-99.2
mzaw9y83
14 Aug 19
Current report (foreign)
12:00am
6-K
EX-99.1
aye1hfw9z y01zh9
14 Aug 19
Current report (foreign)
12:00am
F-3
v29w4i07uh 5w
7 Aug 19
Shelf registration (foreign)
12:00am
6-K
EX-99.1
kk3i 0syxnr6wtg5r4
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
POS AM
bki2y ovuafycmtg
15 Jul 19
Prospectus update (post-effective amendment)
5:15pm
6-K
EX-99.1
pmonzt 09
14 Feb 19
At Market Issuance Sales Agreement
8:13am
424B5
u8kaft
14 Feb 19
Prospectus supplement for primary offering
8:06am
6-K
EX-99.2
1xzdzoiik7pn bboya
14 Feb 19
Current report (foreign)
7:55am
6-K
EX-99.1
c3c56rvt0zxzknr
14 Feb 19
Current report (foreign)
7:55am
6-K
EX-99.2
w26u52l4z6a fvkzf0v2
14 Nov 18
Current report (foreign)
7:00am
6-K
EX-99.1
egu6rh82 6wva9o
14 Nov 18
Current report (foreign)
7:00am
POS AM
t3ygt 0x2f83
12 Oct 18
Prospectus update (post-effective amendment)
5:05pm
6-K
EX-99.1
cdaeda6illcy0t
9 Oct 18
Current report (foreign)
5:21pm